Samit Hirawat, EVP, Chief Med.Offr, Drug Development at BRISTOL MYERS SQUIBB CO (BMY), bought 3,660 shares at $54.68 ($200K) on 2024-11-01, disclosed to the SEC on 2024-11-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.68 | 1,830 | $100K | 50.0% |
| 2 | $54.68 | 1,830 | $100K | 50.0% |
| Total | $54.68 avg | 3,660 | $200K | 100% |
| Filing → |